These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 29946148)

  • 1. Metformin add-on continuous subcutaneous insulin infusion on precise insulin doses in patients with type 2 diabetes.
    Li FF; Liu BL; Yin GP; Yan RN; Zhang DF; Wu JD; Ye L; Su XF; Ma JH
    Sci Rep; 2018 Jun; 8(1):9713. PubMed ID: 29946148
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Randomized Trial of Insulin Glargine plus Oral Hypoglycemic Agents versus Continuous Subcutaneous Insulin Infusion to Treat Newly Diagnosed Type 2 Diabetes.
    Lin S; Chen M; Chen W; Lin K; Mu P; Zhu B; Xu W; Wang M; Weng J; Zeng L
    J Diabetes Res; 2018; 2018():2791584. PubMed ID: 30420969
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of saxagliptin add-on therapy to insulin on blood glycemic fluctuations in patients with type 2 diabetes: A randomized, control, open-labeled trial.
    Li FF; Jiang LL; Yan RN; Zhu HH; Zhou PH; Zhang DF; Su XF; Wu JD; Ye L; Ma JH
    Medicine (Baltimore); 2016 Oct; 95(43):e5229. PubMed ID: 27787387
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Young onset type 2 diabetic patients might be more sensitive to metformin compared to late onset type 2 diabetic patients.
    Li FF; Liu BL; Yin GP; Zhang DF; Zhai XF; Chen MY; Su XF; Wu JD; Ye L; Ma JH
    Sci Rep; 2017 Nov; 7(1):16382. PubMed ID: 29180640
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Management of glycemic variation in diabetic patients receiving parenteral nutrition by continuous subcutaneous insulin infusion (CSII) therapy.
    Li FF; Zhang WL; Liu BL; Zhang DF; Chen W; Yuan L; Chen MY; Zhai XF; Wu JD; Su XF; Ye L; Cao HY; Ma JH
    Sci Rep; 2018 Apr; 8(1):5888. PubMed ID: 29651052
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Continuous subcutaneous insulin infusion combined with liraglutide reduced glycemic variability and oxidative stress in type 2 diabetes mellitus: a study based on the flash glucose monitoring system.
    Li LQ; Yao MY; Ma JX; Xue P; Li YK
    Endocr J; 2019 Oct; 66(10):871-880. PubMed ID: 31243192
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Exenatide Add-on to Continuous Subcutaneous Insulin Infusion Therapy Reduces Bolus Insulin Doses in Patients with Type 2 Diabetes: A Randomized, Controlled, Open-Label Trial.
    Li FF; Jiang L; Fu L; Zhu HH; Zhou P; Zhang D; Su XF; Wu JD; Ye L; Ma JH
    Diabetes Ther; 2017 Feb; 8(1):177-187. PubMed ID: 27995593
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Improvement of β-cell function ameliorated glycemic variability in patients with newly diagnosed type 2 diabetes after short-term continuous subcutaneous insulin infusion or in combination with sitagliptin treatment: a randomized control trial.
    Yuan G; Hu H; Wang S; Yang Q; Yu S; Sun W; Qian W; Mao C; Zhou L; Chen D; Wang Z; Gong Q; Wang D
    Endocr J; 2015; 62(9):817-34. PubMed ID: 26194272
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Glucose Variability and Time in Range in Type 2 Diabetes Treated with U-500R by Pump or Injection: CGM Findings from the VIVID Study.
    Blevins T; Lane W; Rodbard D; Sindelar D; Fan L; Ellinor K; Ilag L; Ly T; Johnson J
    Diabetes Technol Ther; 2021 Jan; 23(1):51-58. PubMed ID: 32631081
    [No Abstract]   [Full Text] [Related]  

  • 10. A comparison of troglitazone and metformin on insulin requirements in euglycemic intensively insulin-treated type 2 diabetic patients.
    Yu JG; Kruszynska YT; Mulford MI; Olefsky JM
    Diabetes; 1999 Dec; 48(12):2414-21. PubMed ID: 10580431
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of Dapagliflozin Adjunct to Insulin on Glycemic Variations in Patients with Newly Diagnosed Type 2 Diabetes: A Randomized, Controlled, Open-Labeled Trial.
    Jiang LL; Zhang P; Liu BL; Yan RN; Ye L; Ma JH; Li FF
    Biomed Res Int; 2021; 2021():6618257. PubMed ID: 34497852
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Short-term continuous subcutaneous insulin infusion combined with insulin sensitizers rosiglitazone, metformin, or antioxidant α-lipoic acid in patients with newly diagnosed type 2 diabetes mellitus.
    Huang Z; Wan X; Liu J; Deng W; Chen A; Liu L; Liu J; Wei G; Li H; Fang D; Li Y
    Diabetes Technol Ther; 2013 Oct; 15(10):859-69. PubMed ID: 23991629
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Continuous subcutaneous insulin infusion versus multiple daily insulin injections in type 2 diabetes: a meta-analysis.
    Monami M; Lamanna C; Marchionni N; Mannucci E
    Exp Clin Endocrinol Diabetes; 2009 May; 117(5):220-2. PubMed ID: 19301231
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Continuous Glucose Monitoring in Newly Diagnosed Type 2 Diabetes Patients Reveals a Potential Risk of Hypoglycemia in Older Men.
    Li FF; Liu BL; Zhu HH; Li T; Zhang WL; Su XF; Wu JD; Wang XQ; Xu N; Yu WN; Yuan Q; Qi GC; Ye L; Lee KO; Ma JH
    J Diabetes Res; 2017; 2017():2740372. PubMed ID: 28271075
    [No Abstract]   [Full Text] [Related]  

  • 15. Comparison of continuous subcutaneous insulin infusion and multiple daily insulin injections in Chinese patients with type 2 diabetes mellitus.
    Yang H; Heng X; Liang C; Liu X; Du W; Li S; Wang Y; Dong Q; Li W; Pan Z; Gong Q; Gao G
    J Int Med Res; 2014 Aug; 42(4):1002-10. PubMed ID: 24965335
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Effect of Acarbose on Glycemic Variability in Patients with Type 2 Diabetes Mellitus Using Premixed Insulin Compared to Metformin (AIM): An Open-Label Randomized Trial.
    Gao F; Ma X; Peng J; Lu J; Lu W; Zhu W; Bao Y; Vigersky RA; Jia W; Zhou J
    Diabetes Technol Ther; 2020 Apr; 22(4):256-264. PubMed ID: 31638433
    [No Abstract]   [Full Text] [Related]  

  • 17. Comparison of the Effects of Continuous Subcutaneous Insulin Infusion and Add-On Therapy with Sitagliptin in Patients with Newly Diagnosed Type 2 Diabetes Mellitus.
    Wan H; Zhao D; Shen J; Lu L; Zhang T; Chen Z
    J Diabetes Res; 2016; 2016():9849328. PubMed ID: 26798658
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of Liraglutide Combined with Short-Term Continuous Subcutaneous Insulin Infusion on Glycemic Control and Beta Cell Function in Patients with Newly Diagnosed Type 2 Diabetes Mellitus: A Pilot Study.
    Ke W; Liu L; Liu J; Chen A; Deng W; Zhang P; Cao X; Liao Z; Xiao H; Liu J; Li Y
    J Diabetes Res; 2016; 2016():6839735. PubMed ID: 26640805
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Continuous glucose profiles with vildagliptin versus sitagliptin in add-on to metformin: results from the randomized Optima study.
    Guerci B; Monnier L; Serusclat P; Petit C; Valensi P; Huet D; Raccah D; Colette C; Quéré S; Dejager S
    Diabetes Metab; 2012 Oct; 38(4):359-66. PubMed ID: 22809630
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of flash glucose-sensing technology in patients with type 2 diabetes treated with liraglutide combined with CSII: a pilot study.
    Yao MY; Li LQ; Ma JX; Xue P; Li YK
    Braz J Med Biol Res; 2020; 53(1):e8652. PubMed ID: 31859911
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.